{
    "authors": [
        {
            "affiliations": [],
            "name": "David M. Nathan"
        },
        {
            "affiliations": [],
            "name": "John B. Buse"
        },
        {
            "affiliations": [],
            "name": "Steven E. Kahn"
        },
        {
            "affiliations": [],
            "name": "Heidi Krause-Steinrauf"
        },
        {
            "affiliations": [],
            "name": "Mary E. Larkin"
        },
        {
            "affiliations": [],
            "name": "Myrlene Staten"
        },
        {
            "affiliations": [],
            "name": "Deborah Wexler"
        },
        {
            "affiliations": [],
            "name": "John M. Lachin"
        }
    ],
    "id": "SP:db151d2f170115ae91a4a8a590621fc32366566c",
    "references": [],
    "sections": [
        {
            "text": "Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254\u20132261\nhttps://doi.org/10.2337/dc22-er03a\nDavid M. Nathan, John B. Buse, Steven E. Kahn, Heidi Krause-Steinrauf, Mary E. Larkin, Myrlene Staten, Deborah Wexler, John M. Lachin, and the GRADE Study Research Group\nThe article cited above outlines the details of the then-upcoming Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) clinical trial, but it was not linked to the GRADE ClinicalTrials.gov identifier. The GRADE ClinicalTrials.gov identifier is NCT01794143.\nThe online version of the article (https://doi.org/10.2337/dc13-0356) has been updated with the ClinicalTrials.gov identifier.\nER R A TU M\nD ow nloaded from http://diabetesjournals.org/care/article-pdf/45/3/759/670511/dc22er03a.pdf by guest on 25 January 2024"
        }
    ],
    "title": "Erratum",
    "year": 2022
}